痤瘡治療藥物市場報告：2030 年趨勢、預測和競爭分析

痤瘡治療藥物的趨勢和預測

2024年至2030年，全球痤瘡治療市場預計複合年成長率為4.2%。這個市場的主要促進因素是生活方式的改變和皮膚病的增加。全球痤瘡治療市場前景廣闊，在外用製劑、口服和注射市場充滿機會。

痤瘡治療藥物按細分市場

本研究按類型、治療層級、給藥方法和地區對全球痤瘡治療進行了預測。

痤瘡治療市場洞察

Lucintel 預測，由於細菌感染病例的增加，在預測期內，發炎疾病仍將是最大的部分。

外用製劑仍然是這個市場中最大的部分。

由於生活方式的改變和疾病盛行率的增加，北美在預測期內仍將是最大的地區。

常問問題

Q1.市場成長預測是多少：

A1. 2024年至2030年，全球痤瘡治療市場預計複合年成長率為4.2%。

Q2. 影響市場成長的關鍵促進因素是：

A2.該市場的主要促進因素是生活方式的改變和皮膚病的增加。

Q3.市場的主要細分市場是：

A3. 痤瘡治療市場前景廣闊，外用製劑、口服和注射藥物市場都有機會。

Q4.市場的主要企業是：

A4. 主要治療痤瘡的藥物公司如下：

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預計，由於細菌感染病例的增加，在預測期內，發炎疾病仍將是最大的部分。

Q6.未來五年預計哪些地區的市場成長最大？

A6. 由於生活方式的改變和疾病盛行率的增加，北美在預測期內仍然是最大的地區。

Q7. 可以客製化報告嗎？

A7。

目錄

第1章執行摘要

第2章全球痤瘡治療市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球痤瘡治療藥物市場趨勢（2018-2023）和預測（2024-2030）
• 按類型分類的全球痤瘡治療藥物市場
  • 致粉刺的
  • 發炎的
  • 囊狀的
  • 手術後/傷口
• 按治療層級的全球痤瘡治療藥物市場
  • 類視色素A
  • 抗生素
  • 荷爾蒙藥物
  • 組合
  • 其他
• 按給藥方法分類的全球痤瘡治療藥物市場
  • 局部的
  • 口服
  • 注射

第4章 2018-2030年區域市場趨勢及預測分析

• 全球痤瘡治療藥物市場（按地區）
• 北美痤瘡治療市場
• 歐洲痤瘡治療市場
• 亞太地區痤瘡治療市場
• 其他地區痤瘡治療藥物市場

第5章 競爭分析

• 產品系列分析
• 業務整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
• 全球痤瘡治療市場新趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球痤瘡治療市場產能
  • 全球痤瘡治療市場的合併、收購和合資企業
  • 認證和許可

第7章主要企業概況

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Acne Drug Trends and Forecast

The future of the global acne drug market looks promising with opportunities in the topical, oral, and injectable markets. The global acne drug market is expected to grow with a CAGR of 4.2% from 2024 to 2030. The major drivers for this market are changing lifestyle and increasing dermatological diseases.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Acne Drug by Segment

The study includes a forecast for the global acne drug by type, therapeutic class, mode of administration, and region.

Acne Drug Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Comedonal
• Inflammatory
• Cystic
• Postsurgical/Wound

Acne Drug Market by Therapeutic Class [Shipment Analysis by Value from 2018 to 2030]:

• Retinoid
• Antibiotic
• Hormonal Agent
• Combination
• Others

Acne Drug Market by Mode of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Topical
• Oral
• Injectable

Acne Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Acne Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies acne drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the acne drug companies profiled in this report include-

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Acne Drug Market Insights

Lucintel forecasts that inflammatory will remain the largest segment over the forecast period due to increasing cases of bacterial infections.

Within this market, topical will remain the largest segment.

North America will remain the largest region over the forecast period due to changing lifestyles and increasing disease incidence.

Features of the Global Acne Drug Market

Market Size Estimates: Acne drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Acne drug market size by type, therapeutic class, mode of administration, and region in terms of value ($B).

Regional Analysis: Acne drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, therapeutic classes, mode of administration, and regions for the acne drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the acne drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for acne drug market?

Answer: The global acne drug market is expected to grow with a CAGR of 4.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the acne drug market?

Answer: The major drivers for this market are changing lifestyle and increasing dermatological diseases.

Q3. What are the major segments for acne drug market?

Answer: The future of the acne drug market looks promising with opportunities in the topical, oral, and injectable markets.

Q4. Who are the key acne drug market companies?

Answer: Some of the key acne drug companies are as follows:

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Q5. Which acne drug market segment will be the largest in future?

Answer: Lucintel forecasts that inflammatory will remain the largest segment over the forecast period due to increasing cases of bacterial infections.

Q6. In acne drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to changing lifestyles and increasing disease incidence.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the acne drug market by type (comedonal, inflammatory, cystic, and postsurgical/wound), therapeutic class (retinoid, antibiotic, hormonal agent, combination, and others), mode of administration (topical, oral, and injectable), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Acne Drug Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Acne Drug Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Acne Drug Market by Type
  • 3.3.1: Comedonal
  • 3.3.2: Inflammatory
  • 3.3.3: Cystic
  • 3.3.4: Postsurgical/Wound
• 3.4: Global Acne Drug Market by Therapeutic Class
  • 3.4.1: Retinoid
  • 3.4.2: Antibiotic
  • 3.4.3: Hormonal Agent
  • 3.4.4: Combination
  • 3.4.5: Others
• 3.5: Global Acne Drug Market by Mode of Administration
  • 3.5.1: Topical
  • 3.5.2: Oral
  • 3.5.3: Injectable

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Acne Drug Market by Region
• 4.2: North American Acne Drug Market
  • 4.2.1: North American Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.2.2: North American Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable
• 4.3: European Acne Drug Market
  • 4.3.1: European Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.3.2: European Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable
• 4.4: APAC Acne Drug Market
  • 4.4.1: APAC Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.4.2: APAC Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable
• 4.5: ROW Acne Drug Market
  • 4.5.1: ROW Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.5.2: ROW Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Acne Drug Market by Type
  • 6.1.2: Growth Opportunities for the Global Acne Drug Market by Therapeutic Class
  • 6.1.3: Growth Opportunities for the Global Acne Drug Market by Mode of Administration
  • 6.1.4: Growth Opportunities for the Global Acne Drug Market by Region
• 6.2: Emerging Trends in the Global Acne Drug Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Acne Drug Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Acne Drug Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Allergan
• 7.2: Bayer
• 7.3: Galderma
• 7.4: Stiefel
• 7.5: Valeant